Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPAIN: Positive Communication for ABG Pain
NCT05434169Completed
- Sponsor
- Hôpital Fribourgeois
- Start
- Mar 2023
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (3 arms), sponsored by Hôpital Fribourgeois. Primary endpoint: Change of Pain. Started Mar 2023; status: completed.
Beyond the preview
Go deeper on NCT05434169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05434169.